China: Key Regulatory Changes from 2022 and Look Ahead to 2023
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices.
China
Learn more about our China work.
AdvaMed’s China Presence
AdvaMed’s office in China sits at the forefront of helping our members navigate China’s large, fast-growing market for medical technologies.
Understanding Regulations in China, Japan and India for Device Expansion and Clinical Operations Excellence
Join us as we explore the advantages and intricacies to setting up a clinical study in China, India and Japan
Key Changes to Clinical Evaluation in China Webinar
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices
Navigating China’s New Regulatory Policy: Order 739 Webinar
Join us for our webinar with Sidley Austin and China Med Device for a comprehensive overview of China’s new regulatory policies.
先进医疗技术协会概况
先进医疗技术协会在全球积极倡导先进医疗技术发展,以促进人类生命健康与各国经济发展。
Global Affairs
AdvaMed members work around the globe, so we do, too.
AdvaMed Code of Ethics 2020 – Chinese
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Export Declaration Of Medical Supplies
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
China’s Process For Allowing The Export Of COVID-19 Products Without NMPA Approval
The Chinese government announced a process to export particular devices without NMPA approval.